LRRK2 and Parkinson disease: We reported here that FL090, acting as an LRRK2 kinase inhibitor, ameliorated motor behavioral deficits and rescued the dopaminergic neuron loss in both intoxicated and α‐syn‐related parkinsonism rodent models.